Topotecan implant (Targeted Therapy Technologies)

N/A

Report date: 2025/03/11 20:00:09

Base Information

Drug NameTopotecan implant (Targeted Therapy Technologies)
Drug Alias NameEpiscleral TopotecanSustained release episcleral topotecanTransscleral topotecanChemoplaque
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsRetinoblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTargeted Therapy Technologies Llc
China Registration ClassN/A

Develop Information

Active CompaniesTargeted Therapy Technologies Llc
Inactive CompaniesN/A
Active IndicationsRetinoblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A